Literature DB >> 1329773

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline.

L P Yu1, G N Smith, K D Brandt, S L Myers, B L O'Connor, D A Brandt.   

Abstract

OBJECTIVE: In vitro studies have indicated that levels of neutral metalloproteinases in osteoarthritic (OA) cartilage are elevated and that doxycycline (doxy) inhibits collagenolytic and gelatinolytic activity in extracts of OA cartilage. The purpose of the present study was to test the effect of oral doxy administration on the severity of cartilage degeneration in OA.
METHODS: OA was induced in 12 adult mongrel dogs by transection of the anterior cruciate ligament (ACL) 2 weeks after dorsal root ganglionectomy. Six dogs received doxy orally from the day after ACL transection until they were killed 8 weeks later; the other 6 served as untreated OA controls.
RESULTS: The unstable knee of each untreated dog exhibited extensive full-thickness cartilage ulceration of the medial femoral condyle. In sharp contrast, cartilage on the distal aspect of the femoral condyle of the unstable knee was grossly normal in 2 doxy-treated dogs, and exhibited only thinning and/or surface irregularity in the others. Degenerative cartilage lesions on the medial trochlear ridge, superficial fibrillation of the medial tibial plateau, and osteophytosis were, however, unaffected by doxy treatment. Collagenolytic activity and gelatinolytic activity in cartilage extracts from OA knees of untreated dogs were 5-fold and 4-fold greater, respectively, than in extracts from dogs given doxy.
CONCLUSION: Prophylactic administration of doxy markedly reduced the severity of OA in weight-bearing regions of the medial femoral condyle. It remains to be determined whether administration of doxy after OA changes have developed is also effective.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329773     DOI: 10.1002/art.1780351007

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

Review 1.  Pharmacologic therapy of osteoarthritis.

Authors:  J P Pelletier; D Choquette; B Haraoui; J P Raynauld; E Rich; J C Fernandes; J Martel-Pelletier
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

2.  Imaging longitudinal changes in articular cartilage and bone following doxycycline treatment in a rabbit anterior cruciate ligament transection model of osteoarthritis.

Authors:  James R Pinney; Carmen Taylor; Ryan Doan; Andrew J Burghardt; Xiaojuan Li; Hubert T Kim; C Benjamin Ma; Sharmila Majumdar
Journal:  Magn Reson Imaging       Date:  2011-11-08       Impact factor: 2.546

Review 3.  The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.

Authors:  Carla R Scanzello; Neal K Moskowitz; Allan Gibofsky
Journal:  Curr Pain Headache Rep       Date:  2007-12

Review 4.  The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.

Authors:  Carla R Scanzello; Neal K Moskowitz; Allan Gibofsky
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

5.  Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses.

Authors:  S Santavirta; M Takagi; Y T Konttinen; T Sorsa; A Suda
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

6.  Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial.

Authors:  R Gapski; J L Barr; D P Sarment; M G Layher; S S Socransky; W V Giannobile
Journal:  J Periodontol       Date:  2004-03       Impact factor: 6.993

7.  Persistence, localization, and external control of transgene expression after single injection of adeno-associated virus into injured joints.

Authors:  Hannah H Lee; Michael J O'Malley; Nicole A Friel; Karin A Payne; Chunping Qiao; Xiao Xiao; Constance R Chu
Journal:  Hum Gene Ther       Date:  2013-04       Impact factor: 5.695

8.  Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis.

Authors:  A Lauhio; Y T Konttinen; H Tschesche; D Nordström; T Salo; J Lähdevirta; L M Golub; T Sorsa
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis.

Authors:  P I Mapp; D A Walsh; J Bowyer; R A Maciewicz
Journal:  Osteoarthritis Cartilage       Date:  2010-01-07       Impact factor: 6.576

10.  The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial.

Authors:  Korakot Nganvongpanit; Peraphan Pothacharoen; Niyada Suwankong; Siriwan Ong-Chai; Prachya Kongtawelert
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.